Page last updated: 2024-08-24

triazoles and Anemias, Iron-Deficiency

triazoles has been researched along with Anemias, Iron-Deficiency in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Fukui, K; Kobayashi, H; Matsuo, A; Matsushita, M; Shinozaki, Y; Yoshiuchi, H	1
Bedford, MR; Ford, SJ; Iqbal, T; Pang, W; Tselepis, C; Tucker, O; Wood, A	1
Batty, KT; Ferrari, P; Maker, GL; Olynyk, JK; Siva, B; Trengove, RD	1

Trials

1 trial(s) available for triazoles and Anemias, Iron-Deficiency

Article	Year
Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:3 Topics: Aged; Anemia, Iron-Deficiency; Area Under Curve; Benzoates; Biological Availability; Chromatography, Liquid; Deferasirox; Drug Administration Schedule; Drug Monitoring; Female; Hematinics; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Pilot Projects; Renal Dialysis; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Triazoles; Western Australia	2013

Article

Year

Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis.

Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:3

Topics: Aged; Anemia, Iron-Deficiency; Area Under Curve; Benzoates; Biological Availability; Chromatography, Liquid; Deferasirox; Drug Administration Schedule; Drug Monitoring; Female; Hematinics; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Pilot Projects; Renal Dialysis; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Triazoles; Western Australia

2013

Other Studies

2 other study(ies) available for triazoles and Anemias, Iron-Deficiency

Article	Year
JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat. European journal of pharmacology, 2021, May-05, Volume: 898 Topics: Anemia, Iron-Deficiency; Animals; Arthritis, Experimental; Biomarkers; Enzyme Inhibitors; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Hematinics; Hepcidins; Hypoxia-Inducible Factor-Proline Dioxygenases; Iron; N-substituted Glycines; Pyridines; Rats, Inbred Lew; Recombinant Proteins; Triazoles	2021
A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy. Annals of the Royal College of Surgeons of England, 2014, Volume: 96, Issue:4 Topics: Adenocarcinoma; Aged; Anemia, Iron-Deficiency; Benzoates; Chelation Therapy; Chemotherapy, Adjuvant; Clinical Trials as Topic; Deferasirox; Esophageal Neoplasms; Esophagectomy; Female; Ferritins; Hemoglobins; Humans; Iron; Iron Chelating Agents; Male; Patient Selection; Prospective Studies; Triazoles	2014

Article

Year

JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.

European journal of pharmacology, 2021, May-05, Volume: 898

Topics: Anemia, Iron-Deficiency; Animals; Arthritis, Experimental; Biomarkers; Enzyme Inhibitors; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Hematinics; Hepcidins; Hypoxia-Inducible Factor-Proline Dioxygenases; Iron; N-substituted Glycines; Pyridines; Rats, Inbred Lew; Recombinant Proteins; Triazoles

2021

A comparative study of the iron status of patients with oesophageal adenocarcinoma to determine suitability for a clinical trial of iron chelation therapy.

Annals of the Royal College of Surgeons of England, 2014, Volume: 96, Issue:4

Topics: Adenocarcinoma; Aged; Anemia, Iron-Deficiency; Benzoates; Chelation Therapy; Chemotherapy, Adjuvant; Clinical Trials as Topic; Deferasirox; Esophageal Neoplasms; Esophagectomy; Female; Ferritins; Hemoglobins; Humans; Iron; Iron Chelating Agents; Male; Patient Selection; Prospective Studies; Triazoles

2014